○Yohei Kitamura1, Nobuhiko Kanaya2,3, Susana Moleirinho3, Ryota Tamura1, Ryo Ueda1, Hikaru Sasaki1,4, Khalid Shah3, Masahiro Toda1 (1.Department of Neurosurgery, Keio University School of Medicine, 2.Department of Gastrointestinal Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 3.Department of Neurosurgery, Brigham and Women's Hospital, 4.Department of Neurosurgery, Tokyo Dental College Ichikawa General Hospital)
Session information
Symposium
[S2] Symposium 2"Onvolytic virus and cell-based therapy”
Mon. Sep 11, 2023 2:15 PM - 3:45 PM Room 2 (1009, 10F, OICC)
Chairs:Toshiyoshi Fujiwara(Okayama University, Institute of Academic and Research, Medicine, Dentistry and Pharmaceutical Sciences),Hirouiki Mizuguchi(Graduate School and School of Pharmaceutical Sciences, Osaka University)
[S2-2] Gene edited and engineered stem cell based virotherapy for melanoma leptomeningeal metastasis
○Nobuhiko Kanaya1,2, Shinji Kuroda1, Toshiyoshi Fujiwara1, Khalid Shah2 (1.Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2.Department of Neurosurgery, Brigham and Women’s Hospital, Harvard medical School)
○Fuminori Sakurai1, Ryosuke Ono1, Hiroyuki Mizuguchi1,2,3,4,5 (1.Graduate School of Pharmaceutical Sciences, Osaka University, 2.National Institute of Biomedical Innovation, Health and Nutrition, 3.Global Center for Advanced Medical Engineering and Informatics, Osaka University, 4.Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, 5.Center for Infectious Disease Education and Research (CiDER), Osaka University)
○Takafumi Nakamura (Tottori University Faculty of Medicine)